Dipeptidyl peptidase 4 and its function against COVID-19

Authors

Keywords:

Dipeptidil peptidasa 4, COVID-19, inhibidores de dipeptidil peptidasa 4

Abstract

Given the appearance of a "new virus" in the of Wuhan city, China, called SARS-CoV-2, which causes the well-known severe acute respiratory syndrome (COVID-19), many scientists are trying to find a solution against the virus that has caused a pandemic. In this search, a transmembrane glycoprotein called dipeptidyl peptidase 4 or DPP-4 was found present on the surface of different types of cells and a target in MERS-Co-V infection, which opens hope by suspecting that DPP- 4 can be a target in different coronaviruses by serving as a therapeutic strategy. Added to this, there are results that find elevated DPP-4 in patients with severe complications from COVID-19, which may be a possible marker of severity. However, there is still little emphasis on the identification and association of this glycoprotein with COVID-19. To this effect, a bibliographic review was carried out on the most significant aspects of Dipeptidyl Peptidase 4 and its function against COVID-19.

Keywords: dipeptidyl peptidase 4; COVID-19; dipeptidyl peptidase 4 inhibitors.

Downloads

Download data is not yet available.

Author Biographies

Marisol Susan Poma Castillo, Universidad Privada Antenor Orrego

Bachiller de Medicina Humana

Victor Hugo Bardales Zuta, Universidad Privada Antenor Orrego

Medico Internista

Published

2022-03-06

How to Cite

1.
Poma Castillo MS, Bardales Zuta VH. Dipeptidyl peptidase 4 and its function against COVID-19. Rev Cubana Med [Internet]. 2022 Mar. 6 [cited 2025 Dec. 13];61(1). Available from: https://revmedicina.sld.cu/index.php/med/article/view/2413

Issue

Section

Review articles